spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Differin 

 HSMN NewsFeed - 23 Mar 2026
Viatris Advances Innovative Portfolio with Approval of Effexor(R) in Japan for Adults with Generalized Anxiety Disorder (GAD)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Sep 2023
Galderma Launches Advanced New Serum with Alastin Skincare(R) - C-Radical Defense Antioxidant Serum
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 18 Jul 2023
Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2022
Ethicon Launches Next Generation Echelon(TM) 3000 Stapler Designed for Exceptional Access and Control
Devices Surgery Product Launch
 HSMN NewsFeed - 24 May 2022
Recruiting Tips: Why Independent Rep Searches Are Different
Devices Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 25 Feb 2022
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 14 Feb 2022
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Nov 2021
Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business
Devices Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2020
BAVENCIO(R) (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Apr 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 31 Mar 2020
Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jan 2020
Astanza Laser Wins Marketing/PR Campaign Of The Year, Training Support Of The Year, And Customer Service Of The Year Awards At The 2019 MyFaceMyBody Global Aesthetic Awards
Devices Dermatology
 HSMN NewsFeed - 17 Jun 2019
Pfizer to Acquire Array BioPharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Apr 2019
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA(R) and INVEGA SUSTENNA(R) for the Treatment of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Biopharmaceuticals
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Devices Dermatology FDA
 HSMN NewsFeed - 25 Sep 2018
Largest Prostate SBRT Studies to Date Show Accuray CyberKnife(R) System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions
Devices Oncology
 HSMN NewsFeed - 18 Dec 2017
Neurotrope Appoints Charles S. Ryan as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Sep 2017
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Jun 2017
Axovant Strengthens Executive Team with Key Management Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 May 2017
NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Apr 2017
Axovant Sciences Announces Appointment of Dr. David Hung as Chief Executive Officer and Expansion of Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 24 Mar 2017
FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA Product Launch
 HSMN NewsFeed - 3 Jan 2017
Allergan Announces FDA Approval of NATRELLE INSPIRA(R) SoftTouch Breast Implants
Devices FDA
 HSMN NewsFeed - 12 Dec 2016
Galderma Announces FDA Approval of Restylane(R) Refyne and Restylane(R) Defyne Dermal Fillers for Treatment of "Laugh Lines"
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 14 Nov 2016
Evena Medical Launches Advanced Mobile Ultrasound Medical Imaging System at MEDICA 2016
Devices Product Launch
 HSMN NewsFeed - 31 Oct 2016
European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Oct 2016
Avita Medical's ReCell(R) devices now treating burns in South Africa and Benelux
Regenerative Medicine Distribution
 HSMN NewsFeed - 20 Sep 2016
Zimmer Biomet Launches VANGUARD(R) Individualized Design Knee Replacement
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 10 Jun 2016
Galderma Celebrates 20th Global Anniversary of Restylane(R)
Biopharmaceuticals Devices Dermatology
 HSMN NewsFeed - 26 Feb 2016
Galderma Delivers Innovation In Dermal Fillers With The Launch Of Two First-In-Class FDA Pivotal Phase III Trials
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 Jan 2016
Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada
Biopharmaceuticals Devices Dermatology Personnel
 HSMN NewsFeed - 18 Nov 2015
Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Oct 2015
Novan Appoints Chief Financial Officer and Chief Commercial Officer to Leadership Team
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Sep 2015
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2015
Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology
Devices Interventional
 HSMN NewsFeed - 2 Jul 2015
Galderma Receives FDA Approval to Market Restylane(R) Lyft with Lidocaine to Correct Age Related Volume Loss in the Cheek Area
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 17 Feb 2015
Galderma Announces Availability of Soolantra(R) (ivermectin) Cream, 1%
Biopharmaceuticals Dermatology FDA Product Launch
 HSMN NewsFeed - 27 Jan 2015
Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien
Devices Interventional Acquisitions
 HSMN NewsFeed - 5 Jan 2015
CardioFocus partners with Japan Lifeline for distribution of the HeartLight Laser Balloon to treat Atrial Fibrillation
Devices Cardiology Distribution
 HSMN NewsFeed - 22 Sep 2014
Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2014
Mirvaso(R) (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 3 Feb 2014
Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy
Devices Gastroenterology FDA
 HSMN NewsFeed - 13 Dec 2013
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 17 Sep 2013
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Aug 2013
Galderma Receives FDA Approval of Mirvaso(R): the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 23 Jul 2013
XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatment of Restless Legs Syndrome/Willis-Ekbom Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 May 2013
Landmark Study Demonstrates Lower Rate of Inappropriate Shocks in Patients with Sorin Dual Chamber ICD Devices
Devices Cardiology
 HSMN NewsFeed - 23 Apr 2013
Nuvo Research announces European launch of Pliaglis(R) by Galderma
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 14 Dec 2012
AcelRx to Present Top-Line Data from Phase 3 Study of Sufentanil NanoTab(R) PCA System vs. IV PCA Morphine at the 66th Annual PostGraduate Assembly in Anesthesiology held in New York City
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 12 Dec 2012
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 3 Dec 2012
Gore Receives CE Mark for New Large Diameter GORE(R) EXCLUDER(R) AAA Endoprosthesis
Devices Interventional Regulatory
 HSMN NewsFeed - 29 Oct 2012
IsoRay's Brain and Lung Cancer Products Showcased at the American Society for Radiation Oncology (ASTRO) Convention
Devices Oncology
 HSMN NewsFeed - 22 Oct 2012
Nuvo and Galderma Announce FDA Approval of Pliaglis(R)
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 7 Jun 2012
GSK and XenoPort Receive FDA Approval for Horizant(R) for Postherpetic Neuralgia
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2011
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX(R) Study for Frozen Shoulder Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2011
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 21 Jun 2011
Kurt May to Join International Stem Cell Corporation as Senior Vice President
Regenerative Medicine Personnel
 HSMN NewsFeed - 22 Jun 2010
International Stem Cell Corporation Names Charles J. Casamento to Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 2 Jun 2010
Teva Announces Launch of Generic Differin(R)
Biopharmaceuticals Generics Dermatology FDA
 HSMN NewsFeed - 27 Apr 2010
CRESTOR(TM) Gains New EU Indication to Prevent Major Cardiovascular Events in High Risk Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Apr 2010
Spinal Elements(R), Inc. Announces First Surgery with Axxion(TM) Minimally Invasive Retractor System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 2 Mar 2010
International Stem Cell Corporation Parthenogenetic Stem Cell Line Shown to Carry the Most Common Immune Genes Matched to the U.S. Population Retains Stem Cell Characteristics over Two Years in Culture, Which is Necessary for Therapeutic Value
Regenerative Medicine
 HSMN NewsFeed - 28 Jan 2010
Abraxis BioScience Confirms Plan to Spin-off Abraxis Health in 2010 and Announces Management Structure
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 15 Sep 2009
Wyeth Presents Data from Five-Year Vertebral Fracture Prevention Study with Bazedoxifene
Biopharmaceuticals
 HSMN NewsFeed - 30 Jun 2009
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 29 May 2009
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Apr 2009
Salix Presents Highly Statistically Significant Results from the Phase III Pivotal Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE)
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 12 Feb 2009
Alios BioPharma, Inc. Completes First Closing of Series A Financing With Commitment of $24 MM From 3 Top-Tier Investors
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Feb 2009
Genta Submits Randomized Study of Tesetaxel in Patients with Advanced Gastric Cancer to FDA for Special Protocol Assessment
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Feb 2009
Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 2 Feb 2009
The Health Authorities of 15 European Countries Give a Collective Green Light to Azzalure For the Treatment of Glabellar Lines, Paving the Way for National Marketing Authorizations
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 20 Jan 2009
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2008
DUSA Announces Update on Nicomide(R) Status
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2008
Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Jun 2008
Senetek PLC Announces Key Personnel Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2008
First Statin Monotherapy to Achieve Regression of Coronary Atherosclerosis by Angiography in a Major Clinical Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 10 Mar 2008
ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Mar 2008
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Feb 2008
Pyratine-6(TM) Study Published in Journal of Drugs in Dermatology
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 26 Feb 2008
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2008
Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 12 Dec 2007
New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2007
Ipsen Grants Galderma Exclusive Rights to Promote and Distribute Dysport(R) in Aesthetic Medicine and Dermatological Indications in Brazil, Argentina and Paraguay
Biopharmaceuticals Distribution Dermatology
 HSMN NewsFeed - 29 Oct 2007
DUSA and River's Edge Announce Settlement Agreement Involving Nicomide(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 9 Oct 2007
Advanced Robotic Catheter Navigation System Aids Patients in Fight Against Heart Disease at Community Hospitals and Major Medical Centers
Devices Surgery
 HSMN NewsFeed - 8 Oct 2007
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 20 Jun 2007
FDA Approves Differin(R) (adapalene) Gel, 0.3% for Acne
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 11 Jun 2007
Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkin's Lymphoma in Europe
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 May 2007
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2007
Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women
Biopharmaceuticals
 HSMN NewsFeed - 11 Apr 2007
Senetek Initiates Clinical Trials of Pyratine 6 for Acne Rosacea
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 25 Mar 2007
First Study to Show Positive Benefit on Atherosclerosis for People With Early Signs of Diseased Arteries
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Feb 2007
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2007
DUSA Pharmaceuticals, Inc.: International Guidelines Recommend Photodynamic Therapy as First-Line Treatment for Actinic Keratoses
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Jan 2007
DUSA Pharmaceuticals Announces Exclusive Agreement with Daewoong to Market DUSA's Levulan'R' Kerastick'R' for Photodynamic Therapy in Asian Territories
Biopharmaceuticals Dermatology Licensing Distribution
 HSMN NewsFeed - 28 Nov 2006
Life Spine Announces FDA Approval of Kinetic(R)
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 28 Nov 2006
Siemens Introduces First Web-Enabled CT; SOMATOM Definition CT Receives FDA Approval for First Six Dual Energy Applications
Devices Radiology FDA
 HSMN NewsFeed - 30 Oct 2006
Mathematical Model Based on Clinical Findings From Cervarix(TM), GSK's Cervical Cancer Candidate Vaccine, Suggests Vaccination Could Reduce Cervical Cancers by up to 80%
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2006
OREXIGEN(TM) Therapeutics Reports Positive Phase II Results for Excalia(TM) Combination-Therapy to Treat Obesity
Biopharmaceuticals
 HSMN NewsFeed - 17 Oct 2006
DUSA Pharmaceuticals Reports Brazilian Regulatory Approval for Levulan
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 11 Jul 2006
DUSA Pharmaceuticals Sues Additional Physicians and a Chemical Supplier for Infringement of its Levulan'R' Photodynamic Therapy Patents
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 Jun 2006
WorldHeart Rotary VAD Implant a Success
Devices Cardiology
Return to NewsFeed  

 Additional items found! 37

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 37 additional stories matching:
Differin
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!